Filing Details

Accession Number:
0001209191-15-051512
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-06-09 17:54:05
Reporting Period:
2015-06-05
Filing Date:
2015-06-09
Accepted Time:
2015-06-09 17:54:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1328143 Adamas Pharmaceuticals Inc ADMS Pharmaceutical Preparations (2834) 421560076
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1604572 Natalie Mcclure C/O Adamas Pharmaceuticals, Inc.
1900 Powell St., Suite 750
Emeryville CA 94608
Svp, Product Development No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-06-05 2,000 $1.76 2,840 No 4 M Direct
Common Stock Disposition 2015-06-05 2,000 $18.95 840 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2015-06-05 2,000 $0.00 2,000 $1.76
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,666 2020-03-03 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
  2. This option is fully vested and exercisable.